KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Astrana Health (ASTH) FCF Margin (2016 - 2025)

Astrana Health's FCF Margin history spans 16 years, with the latest figure at 0.77% for Q3 2025.

  • For Q3 2025, FCF Margin fell 584.0% year-over-year to 0.77%; the TTM value through Sep 2025 reached 3.35%, down 71.0%, while the annual FY2024 figure was 2.17%, 69.0% down from the prior year.
  • FCF Margin for Q3 2025 was 0.77% at Astrana Health, down from 13.67% in the prior quarter.
  • Across five years, FCF Margin topped out at 21.07% in Q4 2022 and bottomed at 7.68% in Q4 2021.
  • The 5-year median for FCF Margin is 3.25% (2023), against an average of 4.4%.
  • The largest YoY upside for FCF Margin was 2876bps in 2022 against a maximum downside of -2394bps in 2022.
  • A 5-year view of FCF Margin shows it stood at 7.68% in 2021, then soared by 374bps to 21.07% in 2022, then crashed by -84bps to 3.47% in 2023, then plummeted by -158bps to 2.03% in 2024, then surged by 138bps to 0.77% in 2025.
  • Per Business Quant, the three most recent readings for ASTH's FCF Margin are 0.77% (Q3 2025), 13.67% (Q2 2025), and 2.19% (Q1 2025).